AZ receives €4.75bn orders for €2.2bn
Biopharmaceutical company AstraZeneca hit a frenzied corporate bond market on Monday with a €2.2bn three tranche bond that contributed to around €6bn of primary supply that day.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts